Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Rice

Showing results (401-410 of 435) with videos related to

Pageof 44
Sort By:
Cancer Letters|March 6, 2012
Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cellsJoshua Bliesath, Nanni Huser, Mayuko Omori, et al.
Cancer Research|December 17, 2010
CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacyAdam Siddiqui-Jain, Denis Drygin, Nicole Streiner, et al.
Cancer Research|September 10, 2009
Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesisDenis Drygin, Adam Siddiqui-Jain, Sean O'Brien, et al.
Bioorganic & Medicinal Chemistry Letters|December 16, 2011
Synthesis and SAR of inhibitors of protein kinase CK2: novel tricyclic quinoline analogsMustapha Haddach, Fabrice Pierre, Collin F Regan, et al.
Nature Medicine|March 1, 1997
Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid proteinW G Rice, J A Turpin, M Huang, et al.
Microbiology Spectrum|December 8, 2023
Quantitative assessment of multiple pathogen exposure and immune dynamics at scaleLusheng Song, Femina Rauf, Ching-Wen Hou, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcriptionJ A Turpin, R W Buckheit, D Derse, et al.
Bioorganic & Medicinal Chemistry|March 1, 1997
A new class of anti-HIV-1 agents targeted toward the nucleocapsid protein NCp7: the 2,2'-dithiobisbenzamidesJ M Domagala, J P Bader, R D Gogliotti, et al.
Molecular Cancer Therapeutics|January 24, 2012
CK2 inhibitor CX-4945 suppresses DNA repair response triggered by DNA-targeted anticancer drugs and augments efficacy: mechanistic rationale for drug combination therapyAdam Siddiqui-Jain, Joshua Bliesath, Diwata Macalino, et al.
Nucleic Acids Research|November 8, 2015
Legume information system (LegumeInfo.org): a key component of a set of federated data resources for the legume familySudhansu Dash, Jacqueline D Campbell, Ethalinda K S Cannon, et al.
Pageof 44

Showing results (401-410 of 435) with videos related to

Sort By:
Pageof 44
Cancer Letters|March 6, 2012
Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cellsJoshua Bliesath, Nanni Huser, Mayuko Omori, et al.
Cancer Research|December 17, 2010
CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacyAdam Siddiqui-Jain, Denis Drygin, Nicole Streiner, et al.
Cancer Research|September 10, 2009
Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesisDenis Drygin, Adam Siddiqui-Jain, Sean O'Brien, et al.
Bioorganic & Medicinal Chemistry Letters|December 16, 2011
Synthesis and SAR of inhibitors of protein kinase CK2: novel tricyclic quinoline analogsMustapha Haddach, Fabrice Pierre, Collin F Regan, et al.
Nature Medicine|March 1, 1997
Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid proteinW G Rice, J A Turpin, M Huang, et al.
Microbiology Spectrum|December 8, 2023
Quantitative assessment of multiple pathogen exposure and immune dynamics at scaleLusheng Song, Femina Rauf, Ching-Wen Hou, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcriptionJ A Turpin, R W Buckheit, D Derse, et al.
Bioorganic & Medicinal Chemistry|March 1, 1997
A new class of anti-HIV-1 agents targeted toward the nucleocapsid protein NCp7: the 2,2'-dithiobisbenzamidesJ M Domagala, J P Bader, R D Gogliotti, et al.
Molecular Cancer Therapeutics|January 24, 2012
CK2 inhibitor CX-4945 suppresses DNA repair response triggered by DNA-targeted anticancer drugs and augments efficacy: mechanistic rationale for drug combination therapyAdam Siddiqui-Jain, Joshua Bliesath, Diwata Macalino, et al.
Nucleic Acids Research|November 8, 2015
Legume information system (LegumeInfo.org): a key component of a set of federated data resources for the legume familySudhansu Dash, Jacqueline D Campbell, Ethalinda K S Cannon, et al.
Pageof 44